Skip to main content
915 TLDR
Health
1 read

Novo Nordisk to Cut Prices of Popular Diabetes and Weight-Loss Medications

KTSMJoseph Choi
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

Novo Nordisk has announced a significant price reduction for its GLP-1 medications, including Ozempic, Wegovy, and Rybelsus, effective January 1, 2027. The list prices for these drugs will be reduced by up to 50%, bringing them down to $675 each. This move is expected to make these essential medications more accessible to patients managing diabetes and obesity, addressing the growing concerns over medication affordability. The change could impact many residents in El Paso who rely on these treatments for their health.

Key Details: • Price reduction effective January 1, 2027. • New list price for each medication will be $675. • Targeted medications include Ozempic, Wegovy, and Rybelsus.

health medications diabetes ozempic wegovy

People & Organizations

Novo Nordisk

Related Articles